venBio

Investment thesis

Backs teams developing treatments with meaningful impact on patient care, addressing the scarcity of patient, expert capital willing to fund companies through the long journey from preclinical science to clinical validation. Invests across clinical stages provided there is meaningful data within three to five years.

Notable portfolio

Sector focus